Higher Dosage of the Epidermal Growth Factor Receptor Mutant Allele in Lung Adenocarcinoma Correlates with Younger Age, Stage IV at Presentation, and Poorer Survival

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Mutant Allele ◽

Growth Factor Receptor ◽

Stage Iv ◽

Younger Age ◽

Epidermal Growth ◽

TP53 mutations in circulating tumor DNA in advanced epidermal growth factor receptor-mutant lung adenocarcinoma patients treated with gefitinib

Translational Oncology ◽

10.1016/j.tranon.2021.101163 ◽

2021 ◽

Vol 14 (9) ◽

pp. 101163

Author(s):

Ruofei Yu ◽

Hua Bai ◽

Tangai Li ◽

Bingyu Gao ◽

Jiefei Han ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Growth Factor Receptor ◽

Circulating Tumor Dna ◽

Tp53 Mutations ◽

Epidermal Growth ◽

Receptor Mutant ◽

Tumor Dna

The features and prognostic impact of extracranial metastases in patients with epidermal growth factor receptor-mutant lung adenocarcinoma

Journal of Cancer Research and Therapeutics ◽

10.4103/jcrt.jcrt_824_17 ◽

2018 ◽

Vol 14 (4) ◽

pp. 799 ◽

Cited By ~ 1

Author(s):

Desheng Hu ◽

Weining Zhen ◽

Jianping Bi ◽

Guang Han ◽

Xueyan Wei ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Growth Factor Receptor ◽

Prognostic Impact ◽

Epidermal Growth ◽

Receptor Mutant ◽

Extracranial Metastases

Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors

European Journal of Cancer ◽

10.1016/j.ejca.2019.10.019 ◽

2020 ◽

Vol 124 ◽

pp. 110-122 ◽

Cited By ~ 7

Author(s):

Ching-Yao Yang ◽

Wei-Yu Liao ◽

Chao-Chi Ho ◽

Kuan-Yu Chen ◽

Tzu-Hsiu Tsai ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Programmed Death Ligand 1 ◽

Programmed Death ◽

Epidermal Growth ◽

Clinical impact of rebiopsy among patients with epidermal growth factor receptor‐mutant lung adenocarcinoma in a real‐world clinical setting

Thoracic Cancer ◽

10.1111/1759-7714.13857 ◽

2021 ◽

Author(s):

Yunha Nam ◽

Ho Cheol Kim ◽

Young‐Chul Kim ◽

Seung Hun Jang ◽

Kye Young Lee ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Real World ◽

Clinical Setting ◽

Growth Factor Receptor ◽

Clinical Impact ◽

Epidermal Growth ◽

Osimertinib: a breakthrough for the treatment of epidermal growth factor receptor mutant lung adenocarcinoma

Translational Cancer Research ◽

10.21037/tcr.2017.01.18 ◽

2017 ◽

Vol 6 (S1) ◽

pp. S117-S121 ◽

Cited By ~ 1

Author(s):

Niki Karachalio ◽

Feliciano Barron Barron ◽

Santiago Viteri ◽

Miguel Angel Molina ◽

Rafael Rosell

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

‘A most malignant malady’: a rare case of laryngeal tuberculosis in epidermal growth factor receptor mutant lung adenocarcinoma

Internal Medicine Journal ◽

10.1111/imj.13560 ◽

2017 ◽

Vol 47 (10) ◽

pp. 1215-1216 ◽

Cited By ~ 1

Author(s):

Angelina Tjokrowidjaja ◽

Doah Cho ◽

Tina Baillie ◽

Rahuram Sivasubramaniam ◽

John Moses ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Rare Case ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Receptor Mutant ◽

Laryngeal Tuberculosis

Risk Prediction for Locoregional Recurrence in Epidermal Growth Factor Receptor-Mutant Stage III-pN2 Lung Adenocarcinoma after Complete Resection: A Multi-center Retrospective Study

Journal of Cancer ◽

10.7150/jca.47119 ◽

2020 ◽

Vol 11 (20) ◽

pp. 6114-6121

Author(s):

Qi-Wen Li ◽

Bo Qiu ◽

Wen-Hua Liang ◽

Jun-Ye Wang ◽

Wan-Ming Hu ◽

...

Keyword(s):

Retrospective Study ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Locoregional Recurrence ◽

Growth Factor Receptor ◽

Complete Resection ◽

Epidermal Growth ◽

Syndecan 4-c-ros oncogene 1 fusion as a mechanism of acquired resistance in epidermal growth factor receptor mutant lung adenocarcinoma

Chinese Medical Journal ◽

10.1097/cm9.0000000000000555 ◽

2019 ◽

Vol 132 (24) ◽

pp. 3015-3017

Author(s):

You-Cai Zhu ◽

Chun-Wei Xu ◽

Qu-Xia Zhang ◽

Wen-Xian Wang ◽

Lei Lei ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Acquired Resistance ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Efficacy of nintedanib plus docetaxel in patients with refractory advanced epidermal growth factor receptor mutant lung adenocarcinoma

Clinical & Translational Oncology ◽

10.1007/s12094-021-02661-2 ◽

2021 ◽

Author(s):

Mariona Riudavets ◽

Joaquim Bosch-Barrera ◽

Luís Cabezón-Gutiérrez ◽

Pilar Diz Taín ◽

Ainhoa Hernández ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Faculty Opinions recommendation of An angiotensin II type 1 receptor mutant lacking epidermal growth factor receptor transactivation does not induce angiotensin II-mediated cardiac hypertrophy.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1047225.497149 ◽

2006 ◽

Author(s):

Søren Sheikh

Keyword(s):

Angiotensin Ii ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Cardiac Hypertrophy ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Receptor Mutant ◽

Receptor Transactivation